health

Stakeholders warn Nigeria’s reliance on imported drug ingredients threatens medicine security

Stakeholders warn Nigeria’s reliance on imported drug ingredients threatens medicine security

Although Nigeria has pharmaceutical companies that manufacture finished medicines, many depend on imported APIs and other raw materials to produce them.

Participants at a stakeholder meeting on accelerating the shift to domestic active pharmaceutical ingredients (APIs) production for priority essential medicines in Nigeria, organised by Nigeria Health Watch in partnership with the World Bank Group in Abuja on Friday

Nigeria’s dependence on imported ingredients to produce medicines could threaten the country’s medicine security, particularly during global supply disruptions.

This was a major concern raised by stakeholders at a meeting on “Accelerating the shift to domestic active pharmaceutical ingredients (APIs) production for priority essential medicines in Nigeria,” organised by Nigeria Health Watch in partnership with the World Bank Group in Abuja on Friday.

Speaking at the meeting, Olumide Okunola of the World Bank Group said Nigerian pharmaceutical manufacturers rely heavily on imported APIs, leaving the country vulnerable to disruptions in international supply chains.

APIs are the substances in medicines that produce their intended therapeutic effects. Although Nigeria has pharmaceutical companies that manufacture finished medicines, many depend on imported APIs and other raw materials to produce them.

Mr Okunola said the dependence exposes local manufacturers to international supply-chain disruptions, trade restrictions and price volatility, potentially affecting the availability and affordability of essential medicines.

He cited the COVID-19 pandemic as an example of how disruptions to global supply chains can expose countries that depend heavily on imported medicines and pharmaceutical inputs.

He said Nigeria did not need to produce every pharmaceutical ingredient locally, but should identify essential APIs that could feasibly be manufactured in the country to guarantee a minimum level of domestic supply.

Mr Okunola also identified inadequate infrastructure, unreliable electricity, limited access to finance and regulatory bottlenecks as constraints to local pharmaceutical production.

He said Nigeria could build on its existing industrial and petrochemical capacity to develop domestic production of selected pharmaceutical ingredients.

He urged policymakers to align health and industrial policies, prioritise APIs used in essential medicines and create an environment that encourages private investment in local manufacturing.

Also speaking, Chris Isokpunwu, permanent secretary of the Federal Ministry of Industry, Trade and Investment, said Nigeria’s dependence on external sources for critical pharmaceutical inputs undermines its ability to guarantee sustainable health security.

“Nigeria cannot achieve sustainable health security while remaining heavily dependent on external sources for critical pharmaceutical inputs,” he said.

Mr Isokpunwu said domestic production of pharmaceutical ingredients should be treated not only as a health-sector priority but also as an economic and industrial development opportunity.

He said local production could strengthen the resilience of medicine supply chains, reduce exposure to international disruptions and foreign exchange pressures, create skilled jobs and retain more economic value within the country.

However, he cautioned against pursuing local production without considering quality, efficiency and affordability.

“We must, however, be careful not to pursue local production at any cost,” he said.

“Our objective must be to produce efficiently, meet internationally recognised quality standards, compete on price and reliability, and progressively integrate into regional and global pharmaceutical value chains.”

He called for a practical roadmap identifying priority APIs, investment requirements, infrastructure needs, incentives, regulatory measures and the institutions responsible for implementation.

Mr Isokpunwu also said the African Continental Free Trade Area could give Nigerian manufacturers opportunities to expand into regional markets and contribute to pharmaceutical value chains across Africa.

Speaking at the meeting, the National Coordinator of the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), Abdu Mukhtar, said the initiative was working with local pharmaceutical manufacturers to identify and prioritise APIs based on Nigeria’s public health needs.

Mr Mukhtar, who was represented by Zara Abba-Aji, said the initiative was also working with the Nigeria Sovereign Investment Authority on excipient manufacturing and exploring ways to improve access to capital and technical expertise for local production.

He said PVAC was engaging a local manufacturer to facilitate access to European Investment Bank financing and technical support, including technology transfer, to strengthen domestic manufacturing capacity.

He also highlighted the initiative’s pooled procurement platform, MediPool, which he said was designed to stimulate demand for locally manufactured medicines.

Mr Mukhtar said efforts to strengthen local production must go beyond manufacturing capacity to address affordability, access to finance, workforce development and demand for locally produced medicines.

Earlier, Vivianne Ihekweazu, managing director of Nigeria Health Watch, said the availability of affordable and quality medicines was central to improving healthcare outcomes and strengthening the country’s health system.

Mrs Ihekweazu said the COVID-19 pandemic exposed the risks of relying heavily on external supply chains for essential medicines and other health products.

She also expressed concern about the slow progress in implementing the federal government’s executive order to increase local production of healthcare products.

She said the convening was intended to bring government, manufacturers, investors and development partners together to identify the policy, regulatory and investment barriers preventing Nigeria from developing a sustainable domestic pharmaceutical ingredients industry.

The concerns come as the federal government intensifies efforts to reduce Nigeria’s dependence on imported medicines and strengthen domestic pharmaceutical manufacturing.

In September, PREMIUM TIMES reported that the federal government was targeting at least 70 per cent local production of essential healthcare products by 2030.

The Minister of State for Health and Social Welfare, Iziaq Salako, said about 87 local manufacturers were benefiting from incentives under a presidential executive order granting tariff relief on pharmaceutical machinery, active pharmaceutical ingredients and excipients.

The government also said it had secured about $2 billion in financing commitments to support local healthcare manufacturing, with approximately 50 Nigerian health companies in advanced discussions for funding.

  • nigeria
  • medicine
  • reliance
  • drug
  • security
  • stakeholder
  • ingredient
  • company

Summaries and tags are generated automatically. Stay informed with VidiaNews.

Related news

Ntim Fordjour: Instead of raiding drug cartels, security agencies stormed my home
health

Ntim Fordjour: Instead of raiding drug cartels, security agencies stormed my home

Ranking Member of Parliament for the Defence and Interior Committee, Rev. John Ntim Fordjour, has questioned the government’s commitment to fighting drug trafficking, recalling how security operatives went to his residence seeking to arrest him after he raised allegations about narcotics activities in Ghana. Rev. Ntim Fordjour invoked the incident to argue that the government should focus its efforts on pursuing suspected drug cartels rather than targeting individuals who raise concerns about narcotics trafficking.

Read →
Medical professionals sound alarm over antibiotic misuse, warn of rising drug resistance
health

Medical professionals sound alarm over antibiotic misuse, warn of rising drug resistance

NAIROBI, Kenya, Nov 20 – Medical and pharmaceutical professionals have raised concern over the growing misuse of antibiotics in Kenya, warning that failure to regulate the use of antimicrobial medicines could undermine treatment of common infections and expose the country to a major public health crisis. The Kenya Medical Association (KMA), Kenya Dental Association (KDA) and Pharmaceutical Society of Kenya (PSK) are calling for stricter controls on the sale and prescription of antibiotics, alongside expanded surveillance and public education to contain antimicrobial resistance (AMR).

Read →
Health Ministry pushes integration of traditional medicine into mainstream healthcare
health

Health Ministry pushes integration of traditional medicine into mainstream healthcare

The Ministry of Health has highlighted the role of traditional medicine in expanding access to healthcare, particularly in rural and underserved communities, as Ghana joined other stakeholders to mark the 24th African Traditional Medicine Day and the 27th Ghana Traditional Medicine Week. She cited the training of about 600 medical herbalists at the Kwame Nkrumah University of Science and Technology (KNUST) and the establishment of herbal medicine units in 55 public hospitals as key steps towards integrating traditional medicine into Ghana’s mainstream healthcare system.

Read →